U.S. Healthcare Services Stock News

DaVita (DVA) drew attention after its stock outperformed both the broader market and the medical sector, with investors positioning ahead of an upcoming earnings report that is expected to show increased EPS and revenue. See our latest analysis for DaVita. At a share price of $236.97, DaVita has built strong momentum, with a 30 day share price return of 13.98% and a year to date share price return of 106.94%. The 3 year total shareholder return of 130.56% points to meaningful longer term...

In the past week, Citizens Financial Group reported second-quarter 2026 results showing higher net interest income of US$1,631 million and net income of US$587 million, reaffirmed its earnings guidance, and declared a US$0.46 per share quarterly dividend while continuing share repurchases. The bank also reported lower net charge-offs of US$135 million versus a year earlier and projected further net interest margin improvement into late 2026 and 2027, underscoring the impact of its...

In recent months, Jazz Pharmaceuticals has drawn fresh attention as investors reassess its sleep-disorder and oncology portfolios amid growing interest in its pipeline progress and franchise positioning. An important angle is how renewed focus on the company’s broader sleep-disorder franchise, following Sunosi’s transition and AXS-12’s FDA filing, intersects with Jazz’s push into targeted therapies for rare cancers. Next, we’ll examine how investor enthusiasm around Jazz’s expanding sleep...

Meta Platforms (META) is back in focus after a flurry of AI infrastructure moves, including hiring AWS executive Dave Brown and entering early talks with Anthropic about a potential multibillion dollar compute lease. See our latest analysis for Meta Platforms. Recent price action reflects that tension between excitement over Meta Platforms’ AI build out and questions about payback timelines, with the share price up 11.92% over the past month but slightly down year to date and over the past...

Home BancShares (HOMB) moved into the spotlight after reporting second quarter 2026 results, combining steady profitability, higher net charge offs, and ongoing share buybacks that give investors several fresh data points to consider. See our latest analysis for Home BancShares. Home BancShares' recent earnings report, higher net charge offs and continued buybacks have arrived alongside building share price momentum, with the stock posting a 30 day share price return of 11.5% and a 5 year...

Honolulu Cookie Company announced that it has expanded its partnership with Square, now running Square’s retail, loyalty, and data tools across 14 locations on Oahu, Maui, Las Vegas, and Guam, and using the platform to support a new flagship store concept opened in July 2026. This deeper deployment highlights how merchants are increasingly relying on Square not just for payments, but as an operations backbone integrating inventory, customer insights, and multi-location expansion. Next, we’ll...

AutoNation recently opened Porsche Hilton Head, a newly built, two-floor, 34,000-square-foot “Destination Porsche” retail and service center in Hardeeville, South Carolina, serving Hilton Head Island, the greater Savannah area and the wider Lowcountry. This addition deepens AutoNation’s presence in a rapidly growing luxury market, potentially reinforcing its high-end brand mix and service-led revenue base. Next, we’ll explore how adding a Generation 5 “Destination Porsche” hub in a...

Facility expansion and index additions frame fresh look at Karman Holdings Karman Holdings (KRMN) is in focus after Karman Space & Defense committed to a $2.7 million expansion of its Horsham, Pennsylvania facility and the stock was added to several S&P small cap and composite indices. See our latest analysis for Karman Holdings. The expansion news and index additions arrive after a tough stretch for Karman Holdings, with the stock’s 90 day share price return down 44.16% and year to date...

Age limits, succession questions, and leadership health are suddenly front-page topics, and that conversation does not stop at politics. For investors, it goes straight to boardrooms, where succession planning and governance can influence how confidently markets view a company’s future. Strong governance does not remove risk, but it can help reduce surprise around leadership changes and policy shifts. This article looks at 3 stocks from our Corporate Governance Leaders screener that appear...

Federal Realty Investment Trust recently announced its 58th consecutive annual dividend increase, underscoring the REIT’s long-running commitment to returning cash to shareholders. This extended dividend growth streak reinforces Federal Realty’s reputation as a reliable income payer, which is especially important for investors focused on steady distributions from retail-focused real estate. Next, we’ll examine how this latest dividend increase influences Federal Realty’s investment...

DoorDash stock has delivered a strong 117.9% gain over the past three years, yet its current valuation checks lean expensive and recent returns over shorter periods have turned weaker. This puts fresh focus on whether the current price still matches the fundamentals. Over the last three years, DoorDash shares are up 117.9%, which puts long term holders in a strong position even as more recent returns have cooled. Regulatory moves such as the ordered 25% pay rise for delivery drivers can lift...

In July 2026, Super Micro Computer announced new Kubernetes Edge AI appliances built with Red Hat OpenShift and Everpure’s Portworx data management platform, delivering a prevalidated, turnkey stack for running AI workloads at distributed edge locations. An interesting aspect of this collaboration is Portworx by Everpure’s software-defined storage, which aggregates local edge server capacity into a resilient, self-healing data platform that continues operating through network outages. Next,...

After a solid multi year run, Neurocrine Biosciences stock now screens as roughly fairly valued on market multiples, and the broader valuation checks point to a more balanced picture than a clear bargain or an obvious stretch. Neurocrine Biosciences has returned 73.4% over the past 5 years, which puts recent gains at the center of any valuation discussion today. Expectations around the durability of its cash generation from existing treatments can support the current price. Any setback in...

XPLR Infrastructure (XIFR) has attracted fresh attention after rebranding from NextEra Energy Partners and shifting its identity while continuing to operate contracted wind, solar, and battery storage assets across the United States. See our latest analysis for XPLR Infrastructure. XPLR Infrastructure's share price has climbed over the past quarter, with a 90 day share price return of 20.2% and an 18.2% year to date gain. The 1 year total shareholder return of 36.3% contrasts with steeply...

Akamai Technologies has been selected as a key security partner for World Wide Technology’s new AI Readiness Model for Operational Resilience, known as the ARMOR framework. The framework is described as the industry’s first holistic, vendor agnostic AI security model, positioning Akamai as a foundational security layer. Akamai will work alongside partners such as NVIDIA and World Wide Technology to help protect critical AI infrastructure and sensitive data. For investors tracking...

Arcos Dorados redemption of sustainability linked notes draws investor focus Arcos Dorados Holdings (ARCO) is set to redeem all of its 6.125% sustainability linked senior notes due 2029, a debt move that puts balance sheet structure and future financing choices in focus. See our latest analysis for Arcos Dorados Holdings. At a share price of $8.23, Arcos Dorados Holdings has seen its short term momentum soften, with the 90 day share price return down 13.37%, while the 1 year total shareholder...

BridgeBio Pharma (BBIO) has drawn investor attention after recent share price moves, with the stock up about 23% over the past month and roughly 6% over the past 3 months. See our latest analysis for BridgeBio Pharma. Beyond the recent monthly move, BridgeBio Pharma’s 1-year total shareholder return of about 75% and 3-year total shareholder return above 100% point to strong momentum, even as the 7-day share price return has slipped 5.25%. If BridgeBio Pharma has sharpened your focus on...

EOG Resources (EOG) has drawn fresh attention after a recent move in its share price, with the stock closing at $139.89 as investors reassess its position in the US energy sector. See our latest analysis for EOG Resources. The recent 1 day share price return of 1.03% to $139.89 extends EOG Resources' upward trend, with a 30 day share price return of 7.62% and a year to date share price return of 30.41%, while the 5 year total shareholder return of 144.31% points to momentum that has built...

With inflation normalizing unevenly across regions, interest rate expectations shifting and energy prices swinging on geopolitics, dependable income is back in focus for many portfolios. That is where the Dividend Powerhouses (3%+ Yield) screener comes in, targeting companies that currently offer yields above 5% and whose dividends are described as well covered, growing and stable. Rather than chasing short term stories, you are zeroing in on cash returns that are designed to show up...

Berkshire Hathaway stock has delivered a 76.3% return over the past 5 years, yet the latest intrinsic value checks suggest the market price may still sit at a discount to what the business is worth. A 76.3% gain over 5 years puts Berkshire Hathaway firmly in positive territory, raising the question of whether the valuation case still points to further upside or if much of the opportunity is already reflected in the price. Greg Abel’s tilt of the portfolio toward large technology and AI...

Centrus Energy (LEU) supplies nuclear fuel components through its Low Enriched Uranium and Technical Solutions segments, giving investors exposure to utility focused contracts across the United States, Japan, the Netherlands, and other international markets. See our latest analysis for Centrus Energy. At a share price of $156.05, Centrus Energy has seen the 1 day share price return rise 6.11%, but the share price return is down 18.46% over 30 days and 42.73% year to date. At the same time,...

Texas Capital Bancshares, Inc. recently appointed Mo Jamous as Managing Director, Chief Digital and Information Officer, putting him in charge of technology strategy, data platforms, AI enablement, and information security while reporting directly to Chairman, President & CEO Rob C. Holmes. Jamous’ background leading digital, AI/ML, and mobile banking initiatives at U.S. Bank and BBVA suggests Texas Capital is concentrating on strengthening its digital capabilities and technology risk...

Enovis (ENOV) recently announced the U.S. launch of CT-RevitL, a next-generation veterinary PBM laser therapy system from its Companion Animal Health business, highlighting the company’s push into non-drug therapies for animal care. See our latest analysis for Enovis. The recent CT-RevitL launch comes as Enovis shares trade at US$27.07, with a 30-day share price return of 23.21% and a 7-day share price return of 5.13%. The 1-year total shareholder return of 2.97% contrasts with a 3-year total...

The Schall Law Firm has launched an investigation into past securities law violations at FirstSun Capital Bancorp, inviting affected investors to join the probe. This legal review raises fresh questions around disclosure practices and governance at the bank, factors that can matter for long-term risk assessment. We will now examine how this new securities law investigation may alter FirstSun’s previously optimistic growth-focused investment narrative. Find 47 companies with promising cash...